A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

Neha Korde; Mattias Carlsten; Min Jung Lee; Alex Minter; Esther Tan; Mary Kwok; Elisabet Manasanch; Manisha Bhutani; Nishant Tageja; Mark Roschewski; Adriana Zingone; Rene Costello; Marcia Mulquin; Diamond Zuchlinski; Irina Maric; Katherine R. Calvo; Raul Braylan; Prashant Tembhare; Constance Yuan; Maryalice Stetler-Stevenson; Jane Trepel; Richard Childs; Ola Landgren

doi:10.3324/haematol.2013.103085

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

Neha Korde
, Mattias Carlsten
, Min Jung Lee
, Alex Minter
, Esther Tan
, Mary Kwok
, Elisabet Manasanch
, Manisha Bhutani
, Nishant Tageja
, Mark Roschewski
, Adriana Zingone
, Rene Costello
, Marcia Mulquin
, Diamond Zuchlinski
, Irina Maric
, Katherine R. Calvo
, Raul Braylan
, Prashant Tembhare
, Constance Yuan
, Maryalice Stetler-Stevenson

Jane Trepel, Richard Childs, Ola Landgren^*

^*Corresponding author for this work

Medicine

Research output: Contribution to journal › Letter › peer-review

119 Scopus citations

Original language	English
Pages (from-to)	e81-e83
Journal	Haematologica
Volume	99
Issue number	6
DOIs	https://doi.org/10.3324/haematol.2013.103085
State	Published - 1 Jun 2014

Keywords

Clinical response
HLA-C binding KIR2D reports
IPH2101
KIR2D blockade
NK-cell function
Smoldering multiple myeloma

Access to Document

10.3324/haematol.2013.103085

Cite this

Korde, N., Carlsten, M., Lee, M. J., Minter, A., Tan, E., Kwok, M., Manasanch, E., Bhutani, M., Tageja, N., Roschewski, M., Zingone, A., Costello, R., Mulquin, M., Zuchlinski, D., Maric, I., Calvo, K. R., Braylan, R., Tembhare, P., Yuan, C., ... Landgren, O. (2014). A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma. Haematologica, 99(6), e81-e83. https://doi.org/10.3324/haematol.2013.103085

@article{130bb7e44258488892b94acb125ef2a8,

title = "A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma",

keywords = "Clinical response, HLA-C binding KIR2D reports, IPH2101, KIR2D blockade, NK-cell function, Smoldering multiple myeloma",

author = "Neha Korde and Mattias Carlsten and Lee, \{Min Jung\} and Alex Minter and Esther Tan and Mary Kwok and Elisabet Manasanch and Manisha Bhutani and Nishant Tageja and Mark Roschewski and Adriana Zingone and Rene Costello and Marcia Mulquin and Diamond Zuchlinski and Irina Maric and Calvo, \{Katherine R.\} and Raul Braylan and Prashant Tembhare and Constance Yuan and Maryalice Stetler-Stevenson and Jane Trepel and Richard Childs and Ola Landgren",

year = "2014",

month = jun,

day = "1",

doi = "10.3324/haematol.2013.103085",

language = "English",

volume = "99",

pages = "e81--e83",

journal = "Haematologica",

issn = "0390-6078",

publisher = "Ferrata Storti Foundation",

number = "6",

}

Korde, N, Carlsten, M, Lee, MJ, Minter, A, Tan, E, Kwok, M, Manasanch, E, Bhutani, M, Tageja, N, Roschewski, M, Zingone, A, Costello, R, Mulquin, M, Zuchlinski, D, Maric, I, Calvo, KR, Braylan, R, Tembhare, P, Yuan, C, Stetler-Stevenson, M, Trepel, J, Childs, R & Landgren, O 2014, 'A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma', Haematologica, vol. 99, no. 6, pp. e81-e83. https://doi.org/10.3324/haematol.2013.103085

TY - JOUR

T1 - A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

AU - Korde, Neha

AU - Carlsten, Mattias

AU - Lee, Min Jung

AU - Minter, Alex

AU - Tan, Esther

AU - Kwok, Mary

AU - Manasanch, Elisabet

AU - Bhutani, Manisha

AU - Tageja, Nishant

AU - Roschewski, Mark

AU - Zingone, Adriana

AU - Costello, Rene

AU - Mulquin, Marcia

AU - Zuchlinski, Diamond

AU - Maric, Irina

AU - Calvo, Katherine R.

AU - Braylan, Raul

AU - Tembhare, Prashant

AU - Yuan, Constance

AU - Stetler-Stevenson, Maryalice

AU - Trepel, Jane

AU - Childs, Richard

AU - Landgren, Ola

PY - 2014/6/1

Y1 - 2014/6/1

KW - Clinical response

KW - HLA-C binding KIR2D reports

KW - IPH2101

KW - KIR2D blockade

KW - NK-cell function

KW - Smoldering multiple myeloma

UR - https://www.scopus.com/pages/publications/84901712243

U2 - 10.3324/haematol.2013.103085

DO - 10.3324/haematol.2013.103085

M3 - Letter

C2 - 24658821

AN - SCOPUS:84901712243

SN - 0390-6078

VL - 99

SP - e81-e83

JO - Haematologica

JF - Haematologica

IS - 6

ER -

A phase II trial of pan-KIR2D blockade with IPH2101 in smoldering multiple myeloma

Keywords

Access to Document

Fingerprint

Cite this